Amniotic fluid levels of S100B protein in normal and trisomy-21 foetuses

Clinica Chimica Acta

Volumn 330, Issue 1-2, 2003, Pages 131-133

  Gazzolo, Diego ^a   Bruschettini, Matteo ^a   Corvino, Valentina ^b   Lituania, Mario ^a   Sarli, Rossana ^c   Bruschettini, Pierluigi ^a   Michetti, Fabrizio ^a  

^a G GASLINI INSTITUTE   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Amniotic fluid; Brain maturation; Foetus; S100B protein; Trisomy 21

Indexed keywords

PROTEIN S100B;

AMNION FLUID; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; FETUS; HUMAN; IMMUNOASSAY; MEASUREMENT; NEWBORN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SAMPLE; TISSUE DISTRIBUTION; TRISOMY 21;

LIA;

EID: 0037375570     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(03)00010-X     Document Type: Article

References (14)

1. Connor J.M., Ferguson-Smith M.A. Essential Medical Genetics. 4th ed. 1993;Blackwell, New York.
2. 2+-binding S100 proteins in the central nervous system. Neurochem. Res. 24:1999;1097-1100.
3. Gazzolo D., Bruschettini M., Corvino V.et al. S100B protein concentrations in amniotic fluid correlate with gestational age and with cerebral ultrasound scanning parameters results in healthy fetuses. Clin. Chem. 47:2001;954-956.
4. Campbell S., Thoms A. Ultrasound measurements of the fetal head to abdomen circumference ratio in the assessment of growth retardation. Br. J. Obstet. Gynaecol. 84:1997;165-174.
5. Jensen R., Marshak D.R., Anderson C., Lukas T.J., Watterson D.M. Characterization of human brain S100 protein fraction: amino acid sequence of S100 beta. J. Neurochem. 45:1985;700-705.
6. Baudier J., Glasser N., Haglid K., Gerard D. Purification, characterization and ion binding properties of human brain S100B protein. Biochim. Biophys. Acta. 790:1984;164-173.
7. Griffin W.S.T., Stanley L.C., Chen L.et al. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 86:1989;7611-7615.
8. Zuckerman J.E., Herschman H.R., Levine L. Appearance of a brain specific antigen (th S-100 protein) during human foetal development. J. Neurochem. 17:1970;247-251.
9. Lauriola L., Sentinelli S., Maggiano N., Michetti F., Cocchia D. Glial like cells in sympathetic neural crest derivatives during human embryogenesis. Detection by S100 immunohistochemistry. Dev. Brain Res. 28:1986;69-74.
10. Lauriola L., Coli A., Cocchia D., Tallini G., Michetti F. Comparative study by S100 and G-FAP immunohistochemistry of glial cell populations in the early stages of human spinal and development. Dev. Brain Res. 37:1987;251-255.
11. Michetti F., Dell'Anna E., Tiberio G., Cocchia D. Immunochemical and immunocytochemical study of S-100 protein in rat adipocytes. Brain Res. 262:1983;352-356.
12. Tiu S.C., Chan W.Y., Heizmann C.W., Shafer B.W., Shu S.Y., Yew D.T. Differential expression of S100B and S100A6(1) in the human fetal cerebral cortex. Brain Res. Dev. Brain Res. 7:2000;159-168.
13. Whitaker-Azmitia P.M., Wingate M., Borella A., Gerlai R., Roder J., Azmitia E.C. Transgenic mice overexpressing the neurotrophic factor S100β show neuronal cytoskeletal and behavioural signs of altered aging processes: implications for Alzheimer's disease and Down's syndrome. Brain Res. 776:1997;51-60.
14. Michetti F., Larocca L.M., Rinelli A., Lauriola L. Immunocytochemical distribution of S-100 protein in patients with Down's syndrome. Acta Neuropathol. (Berl.). 80:1990;475-478.